Cardiovascular Cell Therapy Research Network

The summary for the Cardiovascular Cell Therapy Research Network grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Cardiovascular Cell Therapy Research Network: - The National Heart, Lung, and Blood Institute (NHLBI) invites applications to participate in the Cardiovascular Cell Therapy Research Network (CCTRN), a cooperative network of cardiovascular cell therapy research centers. The goal of the Network is to promote the evaluation of novel cell therapy treatment strategies for individuals with cardiovascular disease. The program will provide support to maintain the necessary infrastructure to develop, coordinate, and conduct multiple collaborative proof-of-concept clinical treatment protocols to improve cardiovascular disease outcomes. - A maximum of five awards will be made for Clinical Centers and one award for a Data Coordinating Center. Approximately $33.7 million (total costs) over 5 years will be awarded. It is anticipated that the annual award for the Data Coordinating Center will be approximately $1,200,000 direct costs in the first year and $1,750,000 each year for years two through five. An additional budget of $8,266,000 for protocols and patient care costs for the entire five-year study period is anticipated. The maximum annual amount for each Clinical Center will be $300,000 direct costs. A maximum of two Clinical Skills Development Core awards will be made for up to $100,000 per year (direct costs). - The cooperative agreement (U01) administrative and funding mechanism of support will be used. - Eligible organizations include domestic, Canadian, or Mexican, for profit and non-profit, public and private institutions such as universities, colleges, hospitals, laboratories, faith-based or community-based organizations, units of state Tribal government; units of local Tribal government, and eligible agencies of the federal government. - Eligible principal investigators include those with the experience and expertise to conduct clinical studies in heart disease. The disciplines and expertise that may be appropriate for this program are cardiology, cardiovascular surgery, cardiovascular imaging, cardiovascular nursing, cardiovascular physiology, stem cell biology, clinical trials management and biostatistics. - Awards for a Clinical Center and a Data Coordinating Center will not be made to the same principal investigator to ensure that data analysis is performed independently of data acquisition. The same institution may apply for both a Clinical Center and Data Coordinating Center award, but the applications for each must be from different individuals and must be submitted as separate applications. - See Section IV.1 for application materials. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088 - A pre-submission meeting will be conducted on October 12, 2005. Details in Section IV. 3.A.1.